{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:04Z","timestamp":1788532024356,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Nn10 Excellent Discipline Construction Program","award":["No. Hepatobiliary and Pancreatic Tumor 2017"],"award-info":[{"award-number":["No. Hepatobiliary and Pancreatic Tumor 2017"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>\n                    Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, with high morbidity and mortality. Postoperative survival is influenced by various factors. Traditional prognostic assessment methods have limitations and often fail to fully reflect individual patient differences. This study aims to analyze physiological, biochemical, and clinical characteristics of HCC patients to explore their association with mortality risk and construct a neural network-based HCC mortality scoring system, offering a novel approach to personalized prognostic evaluation. This retrospective study included 327 HCC patients admitted to a tertiary hospital between June 2020 and June 2022. Univariate and multivariate analyses were conducted to evaluate the relationship between biomarkers (e.g., lymphocytes, neutrophils, alanine aminotransferase [ALT], aspartate aminotransferase [AST]) and clinical features (e.g., number of lesions, imaging stages, microvascular invasion) with mortality risk. A neural network model was then constructed to develop an HCC mortality scoring system, and its predictive performance was assessed. Both univariate and multivariate analyses identified significant predictors of postoperative mortality risk, including lymphocytes (HR\u2005=\u20051.06,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), ALT (HR\u2005=\u20050.98,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.005), AST (HR\u2005=\u20051.03,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003), and the number of lesions (\u22653, HR\u2005=\u200511.87,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The neural network model based on these factors demonstrated good performance in predicting survival among non-deceased patients (precision 78%, recall 84%), but its performance for the mortality category was suboptimal. Biomarkers such as lymphocytes, ALT, and AST, as well as clinical features including the number of lesions and imaging stages, are significant predictors of postoperative mortality risk in HCC patients. This study is the first to develop an HCC mortality scoring system using a neural network model, providing scientific support for personalized prognostic evaluation and precise treatment of HCC.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048803","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:00:24Z","timestamp":1778896824000},"page":"e48803","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of postoperative mortality risk in hepatocellular carcinoma based on biomarkers and neural network models"],"prefix":"10.1097","volume":"105","author":[{"given":"Yingchen","family":"Li","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9545-1295","authenticated-orcid":false,"given":"Ruibao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends.","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20260904","first-page":"mtsi.v4i4.2024.614","article-title":"Hepatocellular carcinoma (HCC).","volume":"4","author":"Pol","year":"2024","journal-title":"Med Trop Sante Int"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma.","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma.","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma.","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"R7-20260904","article-title":"Use of the child pugh score in liver disease.","author":"Tsoris","year":"2026","journal-title":"StatPearls"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41416-023-02368-x","article-title":"Can TILs supplement the TNM staging system (as TNM-immune).","volume":"129","author":"Almangush","year":"2023","journal-title":"Br J Cancer"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update.","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.","volume":"41","author":"Marrero","year":"2005","journal-title":"Hepatology"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma.","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005350300038","article-title":"Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).","volume":"38","author":"Kudo","year":"2003","journal-title":"J Gastroenterol"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00268-008-9552-6","article-title":"Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.","volume":"32","author":"Gomez","year":"2008","journal-title":"World J Surg"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajcn\/71.2.583","article-title":"Weight loss and elevated gluconeogenesis from alanine in lung cancer patients.","volume":"71","author":"Leij-Halfwerk","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.3934\/mbe.2024302","article-title":"A neural network model for goat gait.","volume":"21","author":"Liu","year":"2024","journal-title":"Math Biosci Eng"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma.","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","article-title":"Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.","volume":"229","author":"Fan","year":"1999","journal-title":"Ann Surg"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more.","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4161\/cc.9.9.11297","article-title":"The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances.","volume":"9","author":"Houghton","year":"2010","journal-title":"Cell Cycle"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ejso.2006.03.050","article-title":"Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma.","volume":"32","author":"Zhou","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma.","volume":"100","author":"Llovet","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma.","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/SLA.0b013e31821ad884","article-title":"Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria.","volume":"254","author":"Lim","year":"2011","journal-title":"Ann Surg"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1245\/s10434-008-9846-9","article-title":"Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.","volume":"15","author":"Sumie","year":"2008","journal-title":"Ann Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:00:39Z","timestamp":1788530439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048803","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2024-12-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}